BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 30312486)

  • 1. Gonadotropin-releasing hormone agonist induces downregulation of tensin 1 in women with endometriosis.
    Rahmawati E; Yang WV; Lei YP; Maurya PK; Chen HW; Tzeng CR
    Acta Obstet Gynecol Scand; 2019 Feb; 98(2):222-231. PubMed ID: 30312486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased Level of Neurotrophic Factor Neuritin 1 in Women with Ovarian Endometriosis after Receiving Gonadotropin-Releasing Hormone Agonist Treatment.
    Rahmawati E; Yang WV; Lei YP; Maurya PK; Chen HW; Tzeng CR
    Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31491902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor necrosis factor-alpha-induced interleukin-8 (IL-8) expression in endometriotic stromal cells, probably through nuclear factor-kappa B activation: gonadotropin-releasing hormone agonist treatment reduced IL-8 expression.
    Sakamoto Y; Harada T; Horie S; Iba Y; Taniguchi F; Yoshida S; Iwabe T; Terakawa N
    J Clin Endocrinol Metab; 2003 Feb; 88(2):730-5. PubMed ID: 12574206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of GnRH agonist therapy on the expression of human heat shock protein 70 in eutopic and ectopic endometria of women with endometriosis.
    Imamura T; Khan KN; Fujishita A; Kitajima M; Hiraki K; Ishimaru T; Masuzaki H
    Eur J Obstet Gynecol Reprod Biol; 2014 Sep; 180():16-23. PubMed ID: 25016551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Levofloxacin or gonadotropin releasing hormone agonist treatment decreases intrauterine microbial colonization in human endometriosis.
    Khan KN; Fujishita A; Muto H; Masumoto H; Ogawa K; Koshiba A; Mori T; Itoh K; Teramukai S; Matsuda K; Nakashima M; Kitawaki J
    Eur J Obstet Gynecol Reprod Biol; 2021 Sep; 264():103-116. PubMed ID: 34298448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of the levonorgestrel-releasing intrauterine system on cell proliferation, Fas expression and steroid receptors in endometriosis lesions and normal endometrium.
    Gomes MK; Rosa-e-Silva JC; Garcia SB; de Sá Rosa-e-Silva AC; Turatti A; Vieira CS; Ferriani RA
    Hum Reprod; 2009 Nov; 24(11):2736-45. PubMed ID: 19661125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of GnRHa on apoptosis and release of VEGF in endometrial cell cultures from patients with adenomyosis.
    Xiao-xia W; Jia-li K; Xue-fei S; Jia Y; Ling-hong D
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 Jan; 28(1):72-3. PubMed ID: 22512052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Uterine ultrasonographic changes during endometriosis treatment: a comparison between levonorgestrel-releasing intrauterine devices and a gonadotropin-releasing hormone agonist.
    Manetta LA; de Paula Martins W; Rosa e Silva JC; de Sá Rosa e Silva AC; Nogueira AA; Ferriani RA
    Ultrasound Med Biol; 2008 Dec; 34(12):1914-8. PubMed ID: 18597921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Influence of gonadotropin releasing hormone agonist on the expression of mRNA of nerve growth factor and its receptors in eutopic endometrial stromal cells].
    Li XY; Leng JH; Lang JH
    Zhonghua Fu Chan Ke Za Zhi; 2012 Jun; 47(6):440-4. PubMed ID: 22932111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Down-regulation of proliferation and up-regulation of apoptosis by gonadotropin-releasing hormone agonist in cultured uterine leiomyoma cells.
    Wang Y; Matsuo H; Kurachi O; Maruo T
    Eur J Endocrinol; 2002 Mar; 146(3):447-56. PubMed ID: 11888853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gonadotropin-releasing hormone and TGF-beta activate MAP kinase and differentially regulate fibronectin expression in endometrial epithelial and stromal cells.
    Luo X; Ding L; Chegini N
    Am J Physiol Endocrinol Metab; 2004 Nov; 287(5):E991-E1001. PubMed ID: 15265761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of medical treatment on apoptosis in eutopic endometrium of patients with endometriosis].
    Deng S; Lang JH; Leng JH; Liu ZF; Sun DW; Zhu L; Tan XJ
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2007 Apr; 29(2):252-6. PubMed ID: 17536279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction of vasomotor symptoms and bone mineral density loss with combined norethindrone and long-acting gonadotropin-releasing hormone agonist therapy of symptomatic endometriosis: a prospective randomized trial.
    Surrey ES; Judd HL
    J Clin Endocrinol Metab; 1992 Aug; 75(2):558-63. PubMed ID: 1386374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in tissue inflammation, angiogenesis and apoptosis in endometriosis, adenomyosis and uterine myoma after GnRH agonist therapy.
    Khan KN; Kitajima M; Hiraki K; Fujishita A; Sekine I; Ishimaru T; Masuzaki H
    Hum Reprod; 2010 Mar; 25(3):642-53. PubMed ID: 20008888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted Imaging of Endometriosis and Image-Guided Resection of Lesions Using Gonadotropin-Releasing Hormone Analogue-Modified Indocyanine Green.
    Peng J; Liu Q; Pu T; Zhang M; Zhang M; Du M; Li G; Zhang X; Xu C
    Mol Imaging; 2023; 2023():6674054. PubMed ID: 38089464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gonadotropin-releasing hormone agonist reduces aromatase cytochrome P450 and cyclooxygenase-2 in ovarian endometrioma and eutopic endometrium of patients with endometriosis.
    Kim YA; Kim MR; Lee JH; Kim JY; Hwang KJ; Kim HS; Lee ES
    Gynecol Obstet Invest; 2009; 68(2):73-81. PubMed ID: 19401614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effects of gossypol and GnRHa on the prostaglandins contents of endometriotic cell and in situ].
    Huang HF; Wang M
    Zhong Xi Yi Jie He Za Zhi; 1991 Sep; 11(9):527-9, 515-6. PubMed ID: 1773465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gonadotropin releasing hormone analogue (GnRHa) alters the expression and activation of Smad in human endometrial epithelial and stromal cells.
    Luo X; Xu J; Chegini N
    Reprod Biol Endocrinol; 2003 Dec; 1():125. PubMed ID: 14678567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regression of the inflammatory microenvironment of the peritoneal cavity in women with endometriosis by GnRHa treatment.
    Nirgianakis K; Bersinger NA; McKinnon B; Kostov P; Imboden S; Mueller MD
    Eur J Obstet Gynecol Reprod Biol; 2013 Oct; 170(2):550-4. PubMed ID: 23993133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implication of biosignatures in the progression of endometriosis.
    Pant A; Moar K; Arora TK; Maurya PK
    Pathol Res Pract; 2024 Feb; 254():155103. PubMed ID: 38237401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.